These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2949154)

  • 1. Plasma atriopeptin before and after peritoneojugular venous shunt for hepatogenic ascites.
    Witte CL; Martinez AP; Witte MH
    N Engl J Med; 1987 Feb; 316(8):487. PubMed ID: 2949154
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human atrial natriuretic factor (hANF) in liver cirrhosis].
    Pidlich J; Müller C; Hartter E; Renner F; Klepetko W; Miholic J; Woloszczuk W
    Acta Med Austriaca; 1987; 14(5):125-9. PubMed ID: 2964160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma atrial natriuretic factor in cirrhotic patients with ascites. Effect of peritoneovenous shunt implantation.
    Klepetko W; Müller C; Hartter E; Miholics J; Schwarz C; Woloszczuk W; Moeschl P
    Gastroenterology; 1988 Sep; 95(3):764-70. PubMed ID: 2969346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Denver peritoneojugular shunt. Current indications].
    Bracci F; Bracaglia C; Zampino MA; Farina F; Cucchiara G
    Minerva Med; 1989 Apr; 80(4):363-6. PubMed ID: 2725937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peritoneojugular shunt for intractable ascites in cirrhotic patients : evaluation of 25 patients].
    Toumieux B
    Gastroenterol Clin Biol; 1982 Dec; 6(12):978-82. PubMed ID: 7160595
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium retention in cirrhosis and ascites: effects of continuous peritoneovenous shunting.
    Wexler MJ; Levy M
    Surg Forum; 1978; 29():473-4. PubMed ID: 401228
    [No Abstract]   [Full Text] [Related]  

  • 8. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of sodium retention and ascites formation in cirrhosis: role of atrial natriuretic factor.
    Wong F; Blendis L
    Semin Liver Dis; 1994 Feb; 14(1):59-70. PubMed ID: 8016663
    [No Abstract]   [Full Text] [Related]  

  • 10. [ANP in the cirrhotic patient. A clinical contribution].
    Parlapiano C; Labellarte A; Primi F; Cervellini P; La Torre F; Paparo SB; Baccarini S; Di Nardo A
    Minerva Endocrinol; 1994 Sep; 19(3):121-6. PubMed ID: 7799893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peritoneojugular shunt in the treatment of idiopathic ascites in the hemodialyzed patient: a clinical case].
    Massari R; Marinelli S; Fulgente R; Summa R
    Chir Ital; 1995; 47(1):55-6. PubMed ID: 8706186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peritoneojugular shunt: progress in the treatment of refractory ascites?].
    Beaugrand M
    Gastroenterol Clin Biol; 1989 Nov; 13(11):899-900. PubMed ID: 2612833
    [No Abstract]   [Full Text] [Related]  

  • 13. [Surgical treatment of the ascitic patient using LeVeen peritoneojugular shunt. Personal case reports].
    Amerio A; Giudici Cipriani A; Cananzi C; Zanelli G; Zinicola N
    Minerva Chir; 1986 Feb; 41(3-4):125-33. PubMed ID: 3515230
    [No Abstract]   [Full Text] [Related]  

  • 14. [Z-C model of a peritoneo-venous shunt apparatus for intractable ascites: experimental and clinical studies].
    Xu Z
    Zhonghua Wai Ke Za Zhi; 1983 Feb; 21(2):89-91. PubMed ID: 6872740
    [No Abstract]   [Full Text] [Related]  

  • 15. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation].
    Mabrut JY; de la Roche E; Adham M; Ducerf C; Baulieux J
    Ann Chir; 1998; 52(7):612-7. PubMed ID: 9805798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioisotope assessment of the function of the LeVeen peritoneo-venous shunt in ascites].
    Lucisano E; Zaniol P; Manenti F; Conti A
    Chir Ital; 1979 Dec; 31(6):1033-7. PubMed ID: 554748
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sapheno-peritoneal shunt for the treatment of ascites].
    Nagy Z; Gyurkovics E; Kaliszky P; Kupcsulik P
    Magy Seb; 2001 Aug; 54(4):235-8. PubMed ID: 11550492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ascites in liver cirrhosis treated with peritoneovenous shunt].
    Ritland S; Stray N; Helgerud P; Bugge-Asperheim B; Bergan A; Rootwelt K
    Tidsskr Nor Laegeforen; 1984 Oct; 104(30):2104-7. PubMed ID: 6506048
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
    Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
    Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.